BOSTON — NanoView Biosciences, Inc., the leader in single exosome characterization, today announced the expansion of its management team with the appointment of David Hanlon, Ph.D. to the position of Vice President, Strategic Collaborations.   The addition is a key part of the company’s strategy to create and expand strategic partnerships within the life sciences, pharmaceutical and diagnostics […]

Company to Accelerate Mass Manufacturing and Commercialization of Proprietary PCR-Free Multi-Omics Technology Following Year of Rapid Growth Cardea Bio, Inc., a Tech+Bio company integrating molecular biology with semiconductors via Graphene-based biology-gated Transistors, announced today a $6.5M series A extension that brings the A round total above $20M. The new capital infusion is led by the […]

EMERYVILLE, Calif.– Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the Opto™ Plasma B Discovery 4.0 workflow. Opto Plasma B Discovery 4.0 is the industry’s premier antibody discovery workflow by advancing from B cells to lead molecules in just 1 week. This workflow enables our customers to: Sample 4x more […]

LEIDEN – BIOKÉ, a business unit of Cell Signaling Technology Europe, announced a signed distribution agreement with Mission Bio, the leader in single-cell DNA sequencing and multi-omics to accelerate discoveries and improve time-to-market for new therapeutics, to distribute Mission Bio’s Tapestri® solution in the Netherlands, Belgium and Luxembourg (Benelux) effective immediately. Mission Bio’s Tapestri Platform is the […]

Expanded In Vitro Modeling Tools Will Enable Researchers to Better Understand the Effects of Advanced Biologics and Gene Therapies BOSTON, Mass. – Emulate, Inc., a leading provider of advanced in vitro models, today announced an application roadmap for their market leading organ-on-a-chip technology that expands beyond small molecule applications and addresses the growing focus on […]

BRANFORD, Conn. — Isoplexis, the leader in single-cell functional proteomics, today announced a $135 million Series D financing comprised of $85 million in equity securities and a $50 million credit facility. The round was led by Perceptive Advisors with participation from other new investors, Ally Bridge Group and funds and accounts managed by BlackRock, as well as other existing investors. IsoPlexis will […]

NanoString’s GeoMx Digital Spatial Profiler Highlighted as a Versatile Platform for High Plex Spatial Analysis of RNA and Protein SEATTLE– NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the journal Nature Methods has selected spatially-resolved transcriptomics as their prestigious Method of the Year for 2020. […]

Proprietary in Situ Single-Cell Omics Technology Speeds Drug & Biomarker Discovery Vizgen, a life sciences company developing the next generation of in situ single-cell genomics, today announced the launch of its Pharma Accelerator Lab in response to high demand from leading pharmaceutical companies who are increasingly turning to single-cell and spatial transcriptomics solutions to accelerate […]

– ScaleReady is a joint venture between Bio-Techne, Fresenius Kabi, and Wilson Wolf – ScaleReady’s mission is to make the business of cell and gene therapy practical and viable by providing the most simple, scalable and versatile manufacturing platform in the industry – ScaleReady will provide sales, marketing, and application support for customers globally ScaleReady, a joint venture […]